September 3, 2021
Viatris Pharmaceutical Japan said on September 1 that it has taken over the marketing authorizations and marketing rights of 14 off-patent drugs from Pfizer Japan. The company has succeeded the marketing rights of four authorized generics (AGs) as well. Of...read more